Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01863381 · ClinicalTrials.gov registry record · NA
Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement
A NA study, sponsored by LifeBridge Health.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01863381 is a NA study that was terminated before completion, run by LifeBridge Health. The registered enrollment target is 5 participants.
The verdict
NCT01863381, a NA study, was terminated before completion, sponsored by LifeBridge Health.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
This research is being done to determine the accuracy of two noninvasive methods of measuring the pressure of the cerebrospinal fluid (CSF), also known as intracranial pressure or ICP.
Interventions
- DEVICE Tympanic membrane displacement (TMD)
- DEVICE DPOAE
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2014-09 |
| Est. Completion | 2015-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01863381
The ClinicalTrials.gov registry entry for NCT01863381 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LifeBridge Health, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tympanic membrane displacement (TMD) is the first listed.
NCT01863381 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01863381 about?
NCT01863381 is a clinical study titled "Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement". This research is being done to determine the accuracy of two noninvasive methods of measuring the pressure of the cerebrospinal fluid (CSF), also known as intracranial pressure or ICP.
What is the current status of trial NCT01863381?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2014-09. Estimated completion is 2015-10.
What interventions are being tested in trial NCT01863381?
The interventions under investigation include: Tympanic membrane displacement (TMD) (DEVICE), DPOAE (DEVICE).
Who is sponsoring clinical trial NCT01863381?
This trial is sponsored by LifeBridge Health, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.